Methadone versus other opioids for refractory malignant bone pain: a pilot randomised controlled study

Kane CM, Hoskin P, Bennett MI (2015) Cancer induced bone pain. BMJ 350:h315. https://doi.org/10.1136/bmj.h315

Article  PubMed  Google Scholar 

Colosia A, Njue A, Bajwa Z, Dragon E, Robinson RL, Sheffield KM, Thakkar S, Richiemer SH (2022) The burden of metastatic cancer-induced bone pain: a narrative review. J Pain Res 15:3399–3412. https://doi.org/10.2147/JPR.S371337

Article  PubMed  PubMed Central  Google Scholar 

Middlemiss T, Laird BJ, Fallon MT (2011) Mechanisms of cancer-induced bone pain. Clin Oncol (Royal College of Radiologists (Great Britain)) 23(6):387–392. https://doi.org/10.1016/j.clon.2011.03.003

Article  CAS  Google Scholar 

van der Velden JM, van der Linden YM, Versteeg AL, Verlaan JJ, Sophie Gerlich A, Pielkenrood BJ, Kasperts N, Verkooijen HM (2018) Evaluation of effectiveness of palliative radiotherapy for bone metastases: a prospective cohort study. J Radiat Oncol 7(4):325–333. https://doi.org/10.1007/s13566-018-0363-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paice JA, Bohlke K, Barton D, Craig DS, El-Jawahri A, Hershman DL, Kong LR, Kurita GP, LeBlanc TW, Mercadante S, Novick KLM, Sedhom R, Seigel C, Stimmel J, Bruera E (2023) Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol 41(4):914–930. https://doi.org/10.1200/JCO.22.02198

Article  PubMed  Google Scholar 

Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y (2019) A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe. J Bone Oncol 14:100212. https://doi.org/10.1016/j.jbo.2018.100212

Article  PubMed  Google Scholar 

Kirou-Mauro AM, Hird A, Wong J, Sinclair E, Barnes EA, Tsao M, Danjoux C, Chow E (2009) Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. J Pain Symptom Manage 37(1):77–84. https://doi.org/10.1016/j.jpainsymman.2007.12.014

Article  PubMed  Google Scholar 

Vieira C, Fragoso M, Pereira D, Medeiros R (2019) Pain prevalence and treatment in patients with metastatic bone disease. Oncol Lett 17(3):3362–3370. https://doi.org/10.3892/ol.2019.10013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laird BJ, Walley J, Murray GD, Clausen E, Colvin LA, Fallon MT (2011) Characterization of cancer-induced bone pain: an exploratory study. Support Care Cancer 19(9):1393–1401. https://doi.org/10.1007/s00520-010-0961-3

Article  PubMed  Google Scholar 

Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G (2014) Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage 47(1):57–76. https://doi.org/10.1016/j.jpainsymman.2013.02.015

Article  PubMed  Google Scholar 

van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ (2016) Update on prevalence of pain in patients with cancer systematic review and meta-analysis. J Pain Symptom Manage 51(6):1070-1090 e1079. https://doi.org/10.1016/j.jpainsymman.2015.12.340

Article  PubMed  Google Scholar 

Zajaczkowska R, Kocot-Kepska M, Leppert W, Wordliczek J (2019) Bone pain in cancer patients: mechanisms and current treatment. Int J Mol Sci 20 (23). https://doi.org/10.3390/ijms20236047

Fallon M, Hoskin PJ, Colvin LA, Fleetwood-Walker SM, Adamson D, Byrne A, Murray GD, Laird BJ (2016) Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain. J Clin Oncol 34(6):550–556. https://doi.org/10.1200/JCO.2015.63.8221

Article  CAS  PubMed  Google Scholar 

Afsharimani B, Kindl K, Good P, Hardy J (2015) Pharmacological options for the management of refractory cancer pain-what is the evidence? Support Care Cancer 23(5):1473–1481. https://doi.org/10.1007/s00520-015-2678-9

Article  CAS  PubMed  Google Scholar 

Ding H, Song Y, Xin W, Sun J, Zhong L, Zhou Q, He C, Gong L, Fang L (2022) Methadone switching for refractory cancer pain. BMC Palliat Care 21(1):191. https://doi.org/10.1186/s12904-022-01076-2

Article  PubMed  PubMed Central  Google Scholar 

McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, Bemben NM, Ray JB, Lapointe BJ, Chou R (2019) Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage 57(3):635-645 e634. https://doi.org/10.1016/j.jpainsymman.2018.12.001

Article  PubMed  Google Scholar 

Sulistio M, Wojnar R, Key S, Kwok J, Al-Rubaie Z, Michael N (2021) The role of methadone in cancer-induced bone pain: a retrospective cohort study. Support Care Cancer 29(3):1327–1335. https://doi.org/10.1007/s00520-020-05606-7

Article  PubMed  Google Scholar 

Michael N, Sulistio M, Wojnar R, Gorelik A (2023) Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study. BMC Palliat Care 22(1):42. https://doi.org/10.1186/s12904-023-01160-1

Article  PubMed  PubMed Central  Google Scholar 

Paice JA, Mulvey M, Bennett M, Dougherty PM, Farrar JT, Mantyh PW, Miaskowski C, Schmidt B, Smith TJ (2017) AAPT diagnostic criteria for chronic cancer pain conditions. J Pain: Off J Am Pain Soc 18(3):233–246. https://doi.org/10.1016/j.jpain.2016.10.020

Article  Google Scholar 

Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, Committee EG (2018) Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 29(Suppl 4):iv166–iv191. https://doi.org/10.1093/annonc/mdy152

Article  CAS  PubMed  Google Scholar 

Thong ISK, Jensen MP, Miro J, Tan G (2018) The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure? Scand J Pain 18(1):99–107. https://doi.org/10.1515/sjpain-2018-0012

Article  PubMed  Google Scholar 

Basch E, Becker C, Rogak LJ, Schrag D, Reeve BB, Spears P, Smith ML, Gounder MM, Mahoney MR, Schwartz GK, Bennett AV, Mendoza TR, Cleeland CS, Sloan JA, Bruner DW, Schwab G, Atkinson TM, Thanarajasingam G, Bertagnolli MM, Dueck AC (2021) Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials 18(1):104–114. https://doi.org/10.1177/1740774520975120

Article  PubMed  Google Scholar 

McLean S, Twomey F (2015) Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence. J Pain Symptom Manage 50(2):248-259 e241. https://doi.org/10.1016/j.jpainsymman.2015.02.029

Article  PubMed  Google Scholar 

Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, Dale O, De Conno F, Fallon M, Hanna M, Haugen DF, Juhl G, King S, Klepstad P, Laugsand EA, Maltoni M, Mercadante S, Nabal M, Pigni A, Radbruch L, Reid C, Sjogren P, Stone PC, Tassinari D, Zeppetella G, European Palliative Care Research C, European Association for Palliative C (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13 (2):e58-68. https://doi.org/10.1016/S1470-2045(12)70040-2

Mercadante S, Caraceni A (2011) Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med 25(5):504–515. https://doi.org/10.1177/0269216311406577

Article  PubMed  Google Scholar 

Fine PG, Portenoy RK (2009) Ad hoc expert panel on evidence review and guidelines for opioid rotation. Establishing “best practices” for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage. 38(3):418–25. https://doi.org/10.1016/j.jpainsymman.2009.06.002

Article  PubMed  PubMed Central  Google Scholar 

Ayonrinde OT, Bridge DT (2000) The rediscovery of methadone for cancer pain management. Med J Aust 173(10):536–540

Article  CAS  PubMed  Google Scholar 

Leppert W (2009) The role of methadone in cancer pain treatment–a review. Int J Clin Pract 63(7):1095–1109. https://doi.org/10.1111/j.1742-1241.2008.01990.x

Article  CAS  PubMed  Google Scholar 

Soares LG (2005) Methadone for cancer pain: what have we learned from clinical studies? Am J Hosp Palliat Care 22(3):223–227. https://doi.org/10.1177/104990910502200312

Article  PubMed  Google Scholar 

Oriani A, Fusi-Schmidhauser T, Guo P (2021) Should end-of-life patients be enrolled as participants in clinical research? A best-fit framework synthesis. J Adv Nurs 77(4):1656–1666. https://doi.org/10.1111/jan.14712

Comments (0)

No login
gif